Document Detail


Systemic hemostasis with recombinant-activated factor VII followed by local thrombolysis with recombinant tissue plasminogen activator in intraventricular hemorrhage.
MedLine Citation:
PMID:  16377837     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: A 51-year-old woman on warfarin thromboprophylaxis for transient ischemic attacks developed sudden onset nausea, vomiting, and decreased mental status, rapidly becoming comatose. Head computed tomography (CT) showed intracerebral hemorrhage, extending into all ventricular chambers, and acute obstructive hematocephalus requiring urgent ventricular drainage. CT angiogram showed no evidence of an aneurysm or vascular malformation. METHODS: The pretreatment international normalized ratio (INR) of 4.9 was rapidly corrected with recombinant activated factor VII and an external ventricular drain was placed. Despite accurate positioning, the ventriculostomy thrombosed and became nonfunctional. Recombinant tissue plasminogen activator was given intraventricularly and resulted in partial ventricular decompression within 24 hours, with dramatic improvement in the patient's level of consciousness. RESULTS: Repeated intraventricular fibrinolysis resulted in further reduction of the intraventricular hematoma within a few days and a good patient outcome. The patient did not require permanent ventricular shunt. CONCLUSION: To our knowledge, this is the first reported case of combined systemic enhancement of hemostasis and local fibrinolysis as a life-saving measure in intracranial hemorrhage.
Authors:
Catalina C Ionita; Joseph Ferrara; David L McDonagh; Peter Grossi; Carmelo Graffagnino
Related Documents :
8887877 - Acquired left ventricular to right atrial intracardiac shunt after myocardial infarctio...
16160907 - Chest stab wound-related coronary artery pseudoaneurysm sealed with a polytetrafluoroet...
8650477 - The apical ventricular lesion in chagas' heart disease.
22981087 - Fatal coronary artery intimal hyperplasia due to amphetamine use.
18466417 - Cardioprotective effect of vanadyl sulfate on ischemia/reperfusion-induced injury in ra...
10399997 - Risk stratification of emergency department patients with acute coronary syndromes usin...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Neurocritical care     Volume:  3     ISSN:  1541-6933     ISO Abbreviation:  Neurocrit Care     Publication Date:  2005  
Date Detail:
Created Date:  2005-12-26     Completed Date:  2006-02-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101156086     Medline TA:  Neurocrit Care     Country:  United States    
Other Details:
Languages:  eng     Pagination:  246-8     Citation Subset:  IM    
Affiliation:
Duke Neurosciences Critical Care Unit, Department of Medicine/Neurology, Duke University Medical Center, Durham, NC 27710, USA. ccionita@yahoo.com
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Anticoagulants / therapeutic use
Cerebral Hemorrhage / complications*,  drug therapy*
Factor VIIa / therapeutic use*
Female
Fibrinolytic Agents / therapeutic use*
Hematoma / drug therapy,  etiology
Hemostatic Techniques
Humans
Intracranial Thrombosis / drug therapy*,  etiology
Middle Aged
Recombinant Proteins
Thalamus / blood supply,  pathology
Tissue Plasminogen Activator / therapeutic use*
Tomography, X-Ray Computed
Treatment Outcome
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
0/Anticoagulants; 0/Fibrinolytic Agents; 0/Recombinant Proteins; 81-81-2/Warfarin; EC 3.4.21.21/Factor VIIa; EC 3.4.21.68/Tissue Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Frameless stereotactic aspiration and thrombolysis of spontaneous intracerebral hemorrhage.
Next Document:  Fatal pulmonary embolism despite an inferior vena cava filter in glioblastoma multiforme.